-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 I2heIDiDXYapMUhhatiYh57SXDzpFvfNPdFnm7q0SqGO1AyRSpTipapCYAB3V2tG
 cTYw/EADitj42OOKjVuVSQ==

<SEC-DOCUMENT>0000851169-02-000005.txt : 20021126
<SEC-HEADER>0000851169-02-000005.hdr.sgml : 20021126
<ACCEPTANCE-DATETIME>20021126134139
ACCESSION NUMBER:		0000851169-02-000005
CONFORMED SUBMISSION TYPE:	NSAR-B
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20020930
FILED AS OF DATE:		20021126
EFFECTIVENESS DATE:		20021126

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H&Q LIFE SCIENCES INVESTORS
		CENTRAL INDEX KEY:			0000884121
		IRS NUMBER:				043147016
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		NSAR-B
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-06565
		FILM NUMBER:		02840658

	BUSINESS ADDRESS:	
		STREET 1:		30 ROWES WHARF
		STREET 2:		HAMBRECHT & QUIST FOURTH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6175740500

	MAIL ADDRESS:	
		STREET 1:		30 ROWES WHARF
		STREET 2:		HAMBRECHT & QUIST 4TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
</SEC-HEADER>
<DOCUMENT>
<TYPE>NSAR-B
<SEQUENCE>1
<FILENAME>answer.fil
<TEXT>
<PAGE>      PAGE  1
000 B000000 09/30/2002
000 C000000 000884121
000 D000000 N
000 E000000 NF
000 F000000 Y
000 G000000 N
000 H000000 N
000 I000000 6.1
000 J000000 A
001 A000000 H&Q LIFE SCIENCES INVESTORS
001 B000000 811-6565
001 C000000 6177728500
002 A000000 30 ROWES WHARF
002 B000000 BOSTON
002 C000000 MA
002 D010000 02110
002 D020000 3328
003  000000 N
004  000000 N
005  000000 N
006  000000 N
007 A000000 N
007 B000000  0
007 C010100  1
007 C010200  2
007 C010300  3
007 C010400  4
007 C010500  5
007 C010600  6
007 C010700  7
007 C010800  8
007 C010900  9
007 C011000 10
008 A000001 HAMBRECHT & QUIST CAPITAL MANAGEMENT LLC
008 B000001 A
008 C000001 801-000000
008 D010001 BOSTON
008 D020001 MA
008 D030001 02110
008 D040001 3328
012 A000001 STATE STREET BANK & TRUST CO.
012 B000001 84-0000000
012 C010001 BOSTON
012 C020001 MA
012 C030001 02110
013 A000001 PRICEWATERHOUSECOOPERS LLP
013 B010001 BOSTON
013 B020001 MA
013 B030001 02110
014 A000001 JP MORGAN CHASE
014 B000001 8-00000000
<PAGE>      PAGE  2
015 A000001 STATE STREET BANK & TRUST CO.
015 B000001 C
015 C010001 BOSTON
015 C020001 MA
015 C030001 02110
015 E010001 X
018  000000 Y
019 A000000 N
019 B000000    0
020 A000001 DEUTSCHE BANK SECURITIES
020 B000001 13-2730828
020 C000001     14
020 A000002 BEAR STEARNS SECURITIES
020 B000002 13-3299429
020 C000002     12
020 A000003 DONALDSON, LUFKIN & JENRETTE
020 B000003 13-2741729
020 C000003      9
020 A000004 FRIEDMAN, BILLINGS & RAMSEY
020 B000004 52-1630477
020 C000004      9
020 A000005 ROBERTSON STEPHENS, INC.
020 C000005      7
020 A000006 PACIFIC GROWTH SECURITIES
020 C000006      6
020 A000007 CIBC OPPENHEIMER
020 C000007      6
020 A000008 BANK OF AMERICA SECURITIES INC.
020 B000008 95-4035346
020 C000008      5
020 A000009 TOM WEISEL PARTNERS
020 C000009      5
020 A000010 MERRILL LYNCH, PIERCE, FENNER & SMITH
020 B000010 13-5674085
020 C000010      4
021  000000       90
022 A000001 GE CREDIT
022 C000001    219406
022 D000001         0
022 A000002 AMERICAN EXPRESS
022 C000002    218003
022 D000002         0
022 A000003 MERRILL LYNCH,PIERCE,FENNER & SMITH
022 B000003 13-5674085
022 C000003    161711
022 D000003      5912
022 A000004 GMAC
022 C000004     21980
022 D000004         0
022 A000005 STATE STREET BANK & TRUST CO.
022 B000005 04-1867445
<PAGE>      PAGE  3
022 C000005     17155
022 D000005         0
022 A000006 ROBERTSON STEPHENS, INC.
022 C000006      2780
022 D000006      1420
022 A000007 PACIFIC GROWTH SECURITIES
022 C000007       660
022 D000007      2411
022 A000008 SG COWEN SECURITIES CORP.
022 C000008      3007
022 D000008         0
022 A000009 GOLDMAN SACHS & CO.
022 B000009 13-5108880
022 C000009      2988
022 D000009         0
022 A000010 FRIEDMAN, BILLINGS & RAMSEY
022 C000010       998
022 D000010         0
023 C000000     662603
023 D000000       9744
024  000000 N
025 D000001       0
025 D000002       0
025 D000003       0
025 D000004       0
025 D000005       0
025 D000006       0
025 D000007       0
025 D000008       0
027  000000 N
028 A010000         0
028 A020000         0
028 A030000         0
028 A040000         0
028 B010000         0
028 B020000         0
028 B030000         0
028 B040000         0
028 C010000         0
028 C020000         0
028 C030000         0
028 C040000         0
028 D010000         0
028 D020000         0
028 D030000         0
028 D040000         0
028 E010000         0
028 E020000         0
028 E030000         0
028 E040000         0
028 F010000         0
<PAGE>      PAGE  4
028 F020000         0
028 F030000         0
028 F040000         0
028 G010000         0
028 G020000         0
028 G030000         0
028 G040000         0
028 H000000         0
030 A000000      0
030 B000000  0.00
030 C000000  0.00
031 A000000      0
031 B000000      0
032  000000      0
033  000000      0
035  000000      0
036 B000000      0
038  000000      0
042 A000000   0
042 B000000   0
042 C000000   0
042 D000000   0
042 E000000   0
042 F000000   0
042 G000000   0
042 H000000   0
043  000000      0
044  000000      0
045  000000 Y
046  000000 N
047  000000 N
048  000000  0.000
048 A010000        0
048 A020000 0.000
048 B010000        0
048 B020000 0.000
048 C010000        0
048 C020000 0.000
048 D010000        0
048 D020000 0.000
048 E010000        0
048 E020000 0.000
048 F010000        0
048 F020000 0.000
048 G010000        0
048 G020000 0.000
048 H010000        0
048 H020000 0.000
048 I010000        0
048 I020000 0.000
048 J010000        0
<PAGE>      PAGE  5
048 J020000 0.000
048 K010000        0
048 K020000 0.000
049  000000 N
050  000000 N
051  000000 N
052  000000 N
053 A000000 N
055 A000000 N
055 B000000 N
056  000000 N
057  000000 N
058 A000000 N
059  000000 Y
060 A000000 Y
060 B000000 Y
061  000000        0
062 A000000 N
062 B000000   0.0
062 C000000   0.0
062 D000000   0.0
062 E000000   0.0
062 F000000   0.0
062 G000000   0.0
062 H000000   0.0
062 I000000   0.0
062 J000000   0.0
062 K000000   0.0
062 L000000   0.0
062 M000000   0.0
062 N000000   0.0
062 O000000   0.0
062 P000000   0.0
062 Q000000   0.0
062 R000000   0.0
063 A000000   0
063 B000000  0.0
066 A000000 Y
066 B000000 N
066 C000000 Y
066 D000000 N
066 E000000 N
066 F000000 N
066 G000000 N
067  000000 N
068 A000000 N
068 B000000 N
069  000000 N
070 A010000 Y
070 A020000 N
070 B010000 Y
<PAGE>      PAGE  6
070 B020000 N
070 C010000 N
070 C020000 N
070 D010000 N
070 D020000 N
070 E010000 N
070 E020000 N
070 F010000 N
070 F020000 N
070 G010000 N
070 G020000 N
070 H010000 N
070 H020000 N
070 I010000 N
070 I020000 N
070 J010000 Y
070 J020000 Y
070 K010000 Y
070 K020000 N
070 L010000 Y
070 L020000 N
070 M010000 Y
070 M020000 N
070 N010000 Y
070 N020000 N
070 O010000 Y
070 O020000 N
070 P010000 N
070 P020000 N
070 Q010000 N
070 Q020000 N
070 R010000 Y
070 R020000 N
071 A000000     29339
071 B000000     38514
071 C000000    169041
071 D000000   17
072 A000000 12
072 B000000      925
072 C000000        8
072 D000000        0
072 E000000        2
072 F000000     2740
072 G000000        0
072 H000000        0
072 I000000       50
072 J000000       67
072 K000000        0
072 L000000      100
072 M000000      140
072 N000000        0
<PAGE>      PAGE  7
072 O000000        0
072 P000000        0
072 Q000000        0
072 R000000       68
072 S000000      159
072 T000000        0
072 U000000        0
072 V000000        0
072 W000000      128
072 X000000     3452
072 Y000000        0
072 Z000000    -2517
072AA000000    28316
072BB000000     6552
072CC010000        0
072CC020000    69655
072DD010000        0
072DD020000        0
072EE000000    27513
073 A010000   0.0000
073 A020000   0.0000
073 B000000   2.8600
073 C000000   0.0000
074 A000000      115
074 B000000        0
074 C000000    30582
074 D000000     2949
074 E000000    45288
074 F000000    77987
074 G000000        0
074 H000000        0
074 I000000        0
074 J000000      953
074 K000000        0
074 L000000       41
074 M000000       19
074 N000000   157934
074 O000000        0
074 P000000        0
074 Q000000        0
074 R010000        0
074 R020000        0
074 R030000        0
074 R040000      349
074 S000000        0
074 T000000   157585
074 U010000    10410
074 U020000        0
074 V010000    15.14
074 V020000     0.00
074 W000000   0.0000
<PAGE>      PAGE  8
074 X000000        0
074 Y000000        0
075 A000000        0
075 B000000   202015
076  000000    11.79
077 A000000 Y
077 B000000 Y
077 C000000 Y
077 Q010000 N
077 Q020000 N
077 Q030000 Y
078  000000 N
080 A000000 FIDELITY & DEPOSIT CO. OF MARYLAND
080 C000000     2000
081 A000000 Y
081 B000000   1
082 A000000 Y
082 B000000       25
083 A000000 N
083 B000000        0
084 A000000 N
084 B000000        0
085 A000000 Y
085 B000000 N
086 A010000      0
086 A020000      0
086 B010000      0
086 B020000      0
086 C010000      0
086 C020000      0
086 D010000      0
086 D020000      0
086 E010000      0
086 E020000      0
086 F010000      0
086 F020000      0
087 A010000 H&Q LIFE SCIENCES INVESTORS
087 A020000 404053100
087 A030000 HQL
088 A000000 N
088 B000000 N
088 C000000 N
088 D000000 N
SIGNATURE   KIMBERLY L CARROLL
TITLE       TREASURER


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.77Q3 CERT
<SEQUENCE>3
<FILENAME>cert_hqlkim.txt
<TEXT>
CERTIFICATIONS

I, Kimberly L. Carroll, certify that:

1. I have reviewed this report on Form N-SAR of H&Q Life Sciences Investors;

2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial information included in this report,
and the financial statements on which the financial information is based,
fairly present in all material respects the financial condition, results of
operations, changes in net assets, and cash flows (if the financial statements
are required to include a statement of cash flows) of the registrant as of,
and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in rule 30a-2(c) under the Investment Company Act) for the registrant and have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this report
the "Evaluation Date"); and

c) presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the Evaluation
Date;

5. The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons performing the
equivalent functions):

a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize, and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls;
and

6. The registrant's other certifying officers and I have indicated in this
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: __November 26, 2002__

/s/ KIMBERLY L. CARROLL

Kimberly L. Carroll
Treasurer

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.77Q3 CERT
<SEQUENCE>4
<FILENAME>cert_hqldan.txt
<TEXT>
CERTIFICATIONS

I, Daniel R. Omstead, certify that:

1. I have reviewed this report on Form N-SAR of H&Q Life Sciences Investors;

2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial information included in this report,
and the financial statements on which the financial information is based,
fairly present in all material respects the financial condition, results of
operations, changes in net assets, and cash flows (if the financial statements
are required to include a statement of cash flows) of the registrant as of,
and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in rule 30a-2(c) under the Investment Company Act) for the registrant and have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this report
the "Evaluation Date"); and

c) presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the Evaluation
Date;

5. The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons performing the
equivalent functions):

a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize, and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls;
and

6. The registrant's other certifying officers and I have indicated in this
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: __November 26, 2002__

/s/ DANIEL R. OMSTEAD

Daniel R. Omstead
President


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>5
<FILENAME>hql_proxy.txt
<TEXT>
ANNUAL MEETING REPORT

	The Annual Meeting was held on June 25, 2002 at 9:00 a.m.  The shareholders
 voted on the following items and the resulting votes are presented below.

(1)	To elect two Trustees of the Fund to hold office for a term of three years
or until their respective successors shall have been duly elected and
qualified.

	For	Withheld 	Broker Non-Votes
	Robert P. Mack, M.D.	8,568,583	126,887	0
	Eric Oddleifson	8,574,178	121,292	0
	Oleg M. Pohotsky	8,507,255	188,215	0

The nominees were elected to serve until the 2005 Annual Meeting of
Shareholders.  The Trustees serving until the 2003 Annual Meeting are Alan
G. Carr and Henri A. Termeer.  The Trustees serving until the 2004 Annual
Meeting are Lawrence S. Lewin and Uwe E. Reinhardt, Ph.D.

(2)	To approve a new investment advisory agreement between the Fund and
Hambrecht & Quist Capital Management LLC.

Shareholders overwhelmingly approved the new investment advisory agreement.

		For	Against 	Abstain	Broker Non-Votes
	8,481,355	121,786	92,329	0

(3)	To ratify the selection of PricewaterhouseCoopers LLP as the Funds
independent accountants for the fiscal year ended September 30, 2002.

Shareholders overwhelmingly ratified the selection of the Independent
Public Accountants.

		For	Against 	Abstain	Broker Non-Votes
	8,592,240	49,084	54,146	0


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>6
<FILENAME>hqlaudit.txt
<TEXT>
November 19, 2002

To the Shareholders and Trustees of
H&Q Life Sciences Investors

In planning and performing our audit of the financial statements
of H&Q Life Sciences Investors the Fund for the year ended
September 30, 2002, we considered its internal control, including
control activities for safeguarding securities, in order to determine
our auditing procedures for the purpose of expressing our opinion
on the financial statements and to comply with the requirements
of Form N-SAR, not to provide assurance on internal control.

The management of the Fund is responsible for establishing and
maintaining internal control.  In fulfilling this responsibility, estimates
and judgments by management are required to assess the expected
benefits and related costs of controls.  Generally, controls that are
relevant to an audit pertain to the entitys objective of preparing
financial statements for external purposes that are fairly presented
in conformity with generally accepted accounting principles.  Those
controls include the safeguarding of assets against unauthorized
acquisition, use or disposition.

Because of inherent limitations in internal control, errors or fraud
may occur and not be detected.  Also, projection of any evaluation
of internal control to future periods is subject to the risk that controls
may become inadequate because of changes in conditions or that the
effectiveness of their design and operation may deteriorate.

Our consideration of internal control would not necessarily disclose
all matters in internal control that might be material weaknesses under
standards established by the American Institute of Certified Public
Accountants.  A material weakness is a condition in which the design
or operation of one or more of the internal control components does not
reduce to a relatively low level the risk that misstatements caused by
error or fraud in amounts that would be material in relation to the
financial statements being audited may occur and not be detected
within a timely period by employees in the normal course of
performing their assigned functions.  However, we noted no matters
involving internal control and its operation, including controls for
safeguarding securities, that we consider to be material weaknesses as
defined above as of September 30, 2002.

This report is intended solely for the information and use of management
and the Trustees of the Fund and the Securities and Exchange Commission
and is not intended to be and should not be used by anyone other than these
specified parties.


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
